Preconditioning intensive training ameliorates reduction of transcription biofactors of PGC1?-pathway in paretic muscle due to cerebral ischemia

dc.contributor.authorAbbasian, Sadegh
dc.contributor.authorRavasi, Ali Asghar
dc.contributor.authorHaghighi, Amir Hossein
dc.contributor.authorAydin, Suna
dc.contributor.authorDelbari, Ahmad
dc.contributor.authorAydin, Suleyman
dc.date.accessioned2026-08-12T17:07:00Z
dc.date.issued2023
dc.departmentFırat Üniversitesi
dc.description.abstractExercise training increases fibronectin type III domain-containing protein 5 (FNDC5/irisin) via the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1 alpha)-pathway. The PGC1 alpha pathway induced FNDCs/irisin changes in response to exercise training and ischemic stroke are not entirely understood. We investigated the relation of the PGC-1 alpha/FNDCs/irisin pathway to exercise training and to the pathophysiology of ischemic stroke in paretic muscles of stroke-induced rat models. We induced cerebral ischemia following completion of high-intensity interval training (HIIT) to evaluate PGC1 alpha-pathway biofactors in paretic muscles. To define the underlying molecular mechanisms for improvement in paretic muscles following cerebral ischemia, we evaluated PCG-1 alpha-pathway factors using immunofluorescence tracking and enzyme-linked immunosorbent assay (ELISA) immunoassay. We found that HIIT for 3 weeks produced increased expression and release of PGC-1 alpha-pathway biomarkers in both the serum and paretic muscle of stroke-induced rats. We also found a close relation between the expression of PCG-lapathway factors in skeletal muscle and their concentration in blood. We found that PGC-1 alpha-pathway biomarkers cause irisin up-regulation following induction of cerebral ischemia. The reduction in neurofunctional deficits following increased PGC-1 alpha-pathway biomarkers suggests that these factors may act as markers of improvement in paretic muscle healing following cerebral ischemia.
dc.description.sponsorshipClinical Neurosciences Research Laboratory (LINC), Santiago de Compostela, Spain; University of Tehran, Tehran, Iran [1023]
dc.description.sponsorshipThis study was supported by the Clinical Neurosciences Research Laboratory (LINC), Santiago de Compostela, Spain, and the University of Tehran, Tehran, Iran [1023].
dc.identifier.doi10.1080/10520295.2022.2098535
dc.identifier.endpage53
dc.identifier.issn1052-0295
dc.identifier.issn1473-7760
dc.identifier.issue1
dc.identifier.orcid0000-0002-0929-3060
dc.identifier.pmid35892280
dc.identifier.scopus2-s2.0-85135133423
dc.identifier.scopusqualityQ2
dc.identifier.startpage46
dc.identifier.urihttps://doi.org/10.1080/10520295.2022.2098535
dc.identifier.urihttps://hdl.handle.net/11508/49468
dc.identifier.volume98
dc.identifier.wosWOS:000831110500001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofBiotechnic & Histochemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectBiofactors
dc.subjectcerebral ischemia
dc.subjectexercise
dc.subjectirisin
dc.subjectmuscle wasting
dc.subjectparetic muscle
dc.subjectPGC1 alpha pathway
dc.subjectrats
dc.subjectstroke
dc.subjecttraining
dc.titlePreconditioning intensive training ameliorates reduction of transcription biofactors of PGC1?-pathway in paretic muscle due to cerebral ischemia
dc.typeArticle

Dosyalar